Teamsters voted 1,113 to 211 to end Cargill’s Fort Morgan lockout, sending a 4,700-head plant back into a thinner U.S. cattle map.
Revolution Medicines’ pan-RAS pill Rasonque won FDA approval after nearly doubling survival in a cancer that G12C drugs never reached.
Garmin’s Fenix 9 Pro adds a titanium case and inReach on every size, but the watch’s satellite radio covers only CONUS, Canada, and Europe.
Jonathan Kuminga took a two-year, $12.4 million Timberwolves deal with a player option after passing on more than $36 million from the Lakers.
The last manual V-12 Lamborghini Murciélago SV is in a no-reserve Ontario auction that U.S. buyers cannot import for about ten years.
JBS wants the leftover Pilgrim's Pride float in New York-listed stock at $28.49, with no cash, after telling that minority it will not back any other...
Anthropic's $30 trillion potential revenue pitch would top SpaceX, but both listings claim overlapping shares of the same AI work market.
Holger Rune wants his first match 11 months after an Achilles rupture to be a home Davis Cup tie in Hillerød, then Tokyo.
Rubicon Research grew Q1 FY27 sales 51.6% and raised margin guidance, as specialty mix and a cheap New Jersey plant test an expensive post-IPO bet.
Ferrari’s Zandvoort floor left Hamilton fourth, yet Mercedes will start title leader Kimi Antonelli last at Monza with 11 races remaining.